Watermark
Go to Asia edition

‘Fantastic’ bonds kick Roche loan into touch

Roche’s plans for a jumbo loan have been thrown into doubt after the Swiss drugs group issued more than $14bn of bonds in Europe this week, adding to the $16bn trade it made last week in the US. The bonds mean Roche has little need to tap the bank market to fund its $42bn hostile bid for Genentech.

  • 26 Feb 2009

The borrower has said that as well as using cash to fund its $86.50 a share offer, it might also issue CP.

“I have absolutely no idea if there will be a loan anymore,” said a banker from an institution set to be one of the lead banks on ...

Please take a trial or subscribe to access this content.

Contact our subscriptions team to discuss your access: subs@globalcapital.com

Or sign up for a trial to gain full access to the entire site for a limited period.

Free Trial
Log in

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.

GlobalCapital European securitization league table

Rank Lead Manager/Arranger Total Volume $m No. of Deals Share % by Volume
View full table
1 BNP Paribas 12,508 23 18.18
2 Bank of America Merrill Lynch (BAML) 8,059 25 11.72
3 Lloyds Bank 5,761 18 8.38
4 Citi 5,606 15 8.15
5 JP Morgan 5,007 7 7.28

Bookrunners of Global Structured Finance

Rank Lead Manager Amount $m No of issues Share %
View full table
For detailed analysis: Dealogic
  • Last updated
  • Today
1 Citi 95,041.28 268 11.13%
2 Bank of America Merrill Lynch 79,274.93 221 9.29%
3 Wells Fargo Securities 69,765.48 197 8.17%
4 JPMorgan 69,438.13 198 8.13%
5 Credit Suisse 57,820.17 147 6.77%